|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2002-6-25
|
|
pubmed:abstractText |
Current immunosuppressive drug treatments for renal transplant recipients result in high one-year graft survival rates. Despite adequate suppression of the immune response directed to the allograft, the immune system remains able to cope with many infectious agents.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine,
http://linkedlifedata.com/resource/pubmed/chemical/E-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Hemocyanin,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Mycophenolic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/keyhole-limpet hemocyanin,
http://linkedlifedata.com/resource/pubmed/chemical/mycophenolate mofetil
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0085-2538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
319-28
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12081594-Adolescent,
pubmed-meshheading:12081594-Adult,
pubmed-meshheading:12081594-Antibody Formation,
pubmed-meshheading:12081594-Cyclosporine,
pubmed-meshheading:12081594-Drug Therapy, Combination,
pubmed-meshheading:12081594-E-Selectin,
pubmed-meshheading:12081594-Female,
pubmed-meshheading:12081594-Hemocyanin,
pubmed-meshheading:12081594-Humans,
pubmed-meshheading:12081594-Hypersensitivity, Delayed,
pubmed-meshheading:12081594-Immunoglobulin G,
pubmed-meshheading:12081594-Immunosuppressive Agents,
pubmed-meshheading:12081594-Intercellular Adhesion Molecule-1,
pubmed-meshheading:12081594-Interferon-gamma,
pubmed-meshheading:12081594-Interleukin-4,
pubmed-meshheading:12081594-Kidney Transplantation,
pubmed-meshheading:12081594-Lymphocyte Activation,
pubmed-meshheading:12081594-Male,
pubmed-meshheading:12081594-Middle Aged,
pubmed-meshheading:12081594-Mycophenolic Acid,
pubmed-meshheading:12081594-Prednisolone
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.
|
|
pubmed:affiliation |
Renal Transplant Unit F4-215, POI Box 22700, 1100 DE Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
